Evaluation of anti-PD-1 Cemiplimab plus anti-LAG-3 REGN3767 in early-stage, high-risk HER2-negative breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL Claudine Isaacs , Rita Nanda , Jo Chien , Meghna S. Trivedi , Erica Stringer-Reasor , Christos Vaklavas , Judy C. Boughey , Amy Sanford , Anne Wallace , Amy S. Clark , Alexandra Thomas , Kathy S. Albain , Laura C. Kennedy , Tara B. Sanft , Kevin Kalinsky , Hyo S. Han , Nicole Williams , Mili Arora , Anthony Elias , Carla Falkson , Smita Asare , Ruixiao Lu , Maria Pitsouni , Amy Wilson , Jane Perlmutter , Hope Rugo , Richard Schwab , W. Fraser Symmans , Nola M. Hylton , Laura Van't Veer , Douglas Yee , Angela DeMichele , Donald Berry , Laura J. Esserman CANCER RESEARCH(2023)
AI 理解论文
溯源树
样例